News

Marketing and Communications Partnership

We are today delighted to announce the launch of a new working partnership with Vivactis – the specialist International biomedical …

EMA Oncology Guidance

The EMA guidance is always invaluable when designing a clinical development program for products destined for the European market, and …

Early Experiences with Scientific Advice through IRIS

We recently submitted a scientific advice (SA)/protocol assistance (PA) request via IRIS for a US based SME with an Orphan …

Brexit and the end of the transition period

EU rules will no longer apply to most of the UK from 31st December 2020. But it’s not that simple! …

Scientific Advice through the EMA Regulatory & Scientific Information Management Platform from October 19th 2020

From October 19th this year, Scientific Advice applications will need to go through the EMA Regulatory and Scientific Information Platform …

The Changing Face of Pharma Communications Online Forum

We at Agos are looking forward to this online gathering of selected senior industry colleagues and expert guests from the …

SME in Europe

Agos Pharma have just renewed the SME status of our Irish subsidiary. This means we can access the excellent benefits …

Borderline Medicines and Medical Devices

A number of our USA clients have come to us for help in Europe when developing a medicinal product or …

Update on Clinical Trial Regulation “Application”

The Clinical Trials Regulation will not be applied, and the Clinical Trial Directive will not be repealed, until full functionality …